Market News AIOpen the app

BIO stock news · Bio-Rad Laboratories, Inc.

Stories about Bio-Rad Laboratories, Inc. (BIO) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for BIO

Follow Bio-Rad Laboratories, Inc. (BIO) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for BIO
Free on the App Store and Google Play, or on the web.
  1. Nov 5, 2026, 4:01 PM ET · Results

    RBC Capital Markets increased its price target for Bio-Rad Laboratories from $390 to $440 after strong earnings and sales growth.

    Good for BIO

    RBC raised its Bio-Rad price target to $440 from $390 and kept its “Outperform” rating. Bio-Rad’s reported sales and adjusted earnings growth make this favorable news.